|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/04 | |
| C07D 519/00 |
| (11) | Patento numeris | 2867236 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13752678.6 |
| Europos patento paraiškos padavimo data | 2013-06-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-05-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-06-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2013/055039 |
| Data | 2013-06-19 |
| (87) | Numeris | WO 2014/001973 |
| Data | 2014-01-03 |
| (30) | Numeris | Data | Šalis |
| 201261666299 P | 2012-06-29 | US | |
| 201361820828 P | 2013-05-08 | US |
| (72) |
GALATSIS, Paul, US
HAYWARD, Matthew Merrill, US
HENDERSON, Jaclyn, US
KORMOS, Bethany Lyn, US
KURUMBAIL, Ravi G, US
STEPAN, Antonia Friederike, US
VERHOEST, Patrick Robert, US
WAGER, Travis T., US
ZHANG, Lei, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | NOVEL 4-(SUBSTITUTED-AMINO)-7H-PYRROLO[2,3-D]PYRIMIDINES AS LRRK2 INHIBITORS |
| NOVEL 4-(SUBSTITUTED-AMINO)-7H-PYRROLO[2,3-D]PYRIMIDINES AS LRRK2 INHIBITORS |